A detailed history of Advisor Group Holdings, Inc. transactions in Galapagos Nv stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 354 shares of GLPG stock, worth $9,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
354
Previous 220 60.91%
Holding current value
$9,600
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$24.2 - $30.67 $3,242 - $4,109
134 Added 60.91%
354 $10,000
Q2 2024

Aug 13, 2024

BUY
$24.78 - $32.48 $3,444 - $4,514
139 Added 171.6%
220 $5,000
Q1 2024

May 10, 2024

BUY
$32.2 - $42.44 $1,384 - $1,824
43 Added 113.16%
81 $2,000
Q4 2023

Feb 12, 2024

SELL
$31.87 - $40.71 $44,108 - $56,342
-1,384 Reduced 97.33%
38 $1,000
Q3 2023

Nov 13, 2023

BUY
$34.17 - $42.98 $23,748 - $29,871
695 Added 95.6%
1,422 $49,000
Q2 2023

Aug 10, 2023

SELL
$37.4 - $44.52 $3,216 - $3,828
-86 Reduced 10.58%
727 $29,000
Q3 2022

Nov 14, 2022

BUY
$42.27 - $57.6 $211 - $288
5 Added 0.62%
813 $34,000
Q2 2022

Aug 10, 2022

SELL
$52.3 - $71.59 $627 - $859
-12 Reduced 1.46%
808 $45,000
Q1 2022

May 04, 2022

BUY
$51.32 - $68.5 $3,130 - $4,178
61 Added 8.04%
820 $52,000
Q3 2021

Nov 05, 2021

SELL
$52.17 - $70.2 $150,666 - $202,737
-2,888 Reduced 79.19%
759 $40,000
Q2 2021

Aug 02, 2021

SELL
$68.86 - $83.34 $55,914 - $67,672
-812 Reduced 18.21%
3,647 $251,000
Q1 2021

May 13, 2021

BUY
$76.15 - $111.94 $21,626 - $31,790
284 Added 6.8%
4,459 $344,000
Q4 2020

Feb 10, 2021

BUY
$96.85 - $148.25 $118,157 - $180,865
1,220 Added 41.29%
4,175 $413,000
Q3 2020

Nov 12, 2020

SELL
$122.47 - $213.56 $63,439 - $110,624
-518 Reduced 14.92%
2,955 $419,000
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $30,981 - $38,618
-167 Reduced 4.59%
3,473 $685,000
Q1 2020

May 18, 2020

BUY
$143.0 - $274.03 $520,520 - $997,469
3,640 New
3,640 $713,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.